Bortezomib Avansor contains bortezomib, a proteasome inhibitor, which helps destroy cancer cells by disrupting their function and growth.
The usual starting dose is 1.3 mg/m² of body surface area twice a week, but your doctor will determine the exact dose based on your specific condition.
The medicine is given as an injection into a vein (intravenously) or under the skin (subcutaneously); the intravenous injection is fast (3-5 seconds), and the subcutaneous injection is given in the thigh or abdomen.
Your doctor will adjust the dose and number of treatment cycles based on how well the treatment works and if you experience side effects, so there is no fixed maximum daily dose.